New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

DelveInsight's Parkinson's Disease Pipeline report depicts a robust space with 130+ active players working to develop 150+ ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

In its last fund raising round last year, Insightec’s valuation was at just $515 million, as emerges from the financials of listed company Elbit Medical, which holds 2% of Insightec.

Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...